Pharmaceutical residues in treated wastewater samples according to Directive (EU) 2024/3019
Analysis to determine the concentrations of organic substances (pharmaceuticals and drug precursors) listed in the revised Urban Wastewater Treatment Directive (EU) 2024/3019.
The analysis includes eight substances that can be very easily treated:
Amisulprid (CAS: 71675-85-9)
Carbamazepine (CAS: 298-46-4)
Citalopram (CAS: 59729-33-8)
Clarithromycin (CAS: 81103-11-9)
Diclofenac (CAS: 15307-86-5)
Hydrochlorothiazide (CAS: 58-93-5)
Metoprolol (CAS: 37350-58-6)
Venlafaxine (CAS: 93413-69-5)
And four substances that can be easily disposed of:
Benzotriazole (CAS: 95-14-7)
Candesartan (CAS: 139481-59-7)
Irbesartan (CAS: 138402-11-6)
Mixture of 4-Methylbenzotriazole (CAS No 29878-31-7) and 6-methyl-benzotriazole (CAS No 136-85-6)
An example test report (with mock data) illustrating the reporting format is available: Example report – Pharmaceuticals in treated wastewater.
This method is suitable for treated wastewater samples with low total solids and dissolved solids content, but we also offer analyses for untreated wastewater. Please check the suitability of the sample matrix with the testing expert when requesting an offer.
- Suitable sample matrices
- Treated wastewater
- Required sample quantity
- 50 mL in a dark glass bottle
- Typical turnaround time
- 3 weeks after receiving the samples
- Detection limit
- Estimated 0.005-0.05 μg/L
- Available quality systems
- Accredited testing laboratory
- Method expert
Questions? We're happy to help.
Questions? We're happy to help.
Ask for an offer
Fill in the form, and we'll reply in one business day.
Have questions or need help? Email us at info@measurlabs.com or call our sales team.
